How much funding has Molbio Diagnostics raised?

Molbio Diagnostics has raised $117.8M in total funding, most recently a Venture Round.

Who are Molbio Diagnostics's investors?

Molbio Diagnostics's investors include Motilal Oswal Private Equity, Temasek.

When was Molbio Diagnostics founded?

Molbio Diagnostics was founded in 2000.

Where is Molbio Diagnostics headquartered?

Molbio Diagnostics is headquartered in Bangalore, India.

What industry is Molbio Diagnostics in?

Molbio Diagnostics operates in Medical Device, Biotech, Healthcare.

How many employees does Molbio Diagnostics have?

Molbio Diagnostics has 501-1000 employees.

Molbio Diagnostics

Redefining global healthcare through future-powered innovations.

Bangalore, India · Founded 2000 · $117.8M raised

Medical Device

Biotech

Healthcare

Headquarters: Bangalore
Employees: 501–1000
Founded: 2000
Business Model: B2B

Website: molbiodiagnostics.com
Total Funding: $117.8M
Last Round: $85.0M Venture RoundSep 2022
Rounds: 2

About

Molbio Diagnostics is an Indian biotech company developing portable, rapid molecular diagnostic solutions for point-of-care settings. Its flagship Truenat platform decentralizes disease testing for TB, COVID-19, and other infectious diseases, enabling diagnosis at the point of care rather than centralized labs. Operating across 80+ countries, the company combines strong R&D through subsidiary Bigtec Labs with commercial scale.

Summary

Molbio Diagnostics is a Medical Device company based in Bangalore, India, founded in 2000. It has raised $117.8M in total across 2 rounds, most recently a $85.0M Venture Round round in Sep 2022. Investors include Motilal Oswal Private Equity and Temasek.

LinkedIn X (Twitter)